Note - they do not link anywhere yet.. that will be added soon.
Scroll down for inactive trials
Trials marked with a *** are duplicates

•  Vaccine: [1841] A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
•  NCT01044966: [1967] A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
•  NCT01026168: [1954] A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
•  NCT01024907: [1966] Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas
•  NCT01020292: [1955] A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
•  NCT01019434: [1957] Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
•  NCT01013285: [1958] Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT01006044: [1973] Prospective, Phase II Clinical Trial to Evaluate Efficacy and Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme Patients After Complete Surgical Resection With Fluorescence Microscope
•  NCT00996723: [1968] Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
•  * * * Duplicate ** NCT00996723: [1960] Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)
•  NCT00990496: [1956] A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
•  NCT00928226: [1939] Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
•  NCT00916409: [1924] Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
•  NCT00912951: [1930] PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme
•  NCT00905060: [1972] PHASE II, Single-arm, Open-label Investigation of HSPPC-96 Vaccine With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00892931: [1926] Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme
•  NCT00890786: [1959] A Study of Bevacizumab (Avastin) Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
•  NCT00890032: [1969] Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme
•  NCT00880061: [1911] An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma
•  NCT00823459: [1902] Phase II Trial of RAD001 in Patients with Recurrent Low Grade Glioma
•  NCT00751270: [1974] A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas
•  NCT00747253: [1879] AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors
•  * * * Duplicate ** NCT00747253: [1892] Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
•  NCT00734682: [1903] A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
•  NCT00694330: [1941] Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
•  NCT00639639: [1971] Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced Lymphopenia
•  NCT00635557: [1925] Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
•  NCT00627224: [1845] Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-Specific T-Cell Adoptive Transfer [ERaDICATe]
•  NCT00615186: [1873] The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00613223: [1940] Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
•  NCT00612001: [1843] Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients
•  NCT00600054: [1961] Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma
•  NCT00589875: [1975] A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma
•  NCT00589784: [1887] Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
•  NCT00589706: [1896] A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 (MAb-425) in High Grade Gliomas
•  NCT00586508: [1912] A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas
•  NCT00576641: [1970] Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
•  NCT00576537: [1840] Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System
•  NCT00576446: [1844] A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
•  NCT00562419: [1861] Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme
•  * * * Duplicate ** NCT00562419: [1886] CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
•  NCT00560144: [1921] Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
•  NCT00555399: [1859] Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme
•  NCT00539552: [1835] Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma
•  NCT00539383: [1872] A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer
•  NCT00539344: [1871] A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
•  NCT00525525: [1858] A Phase II study of Bevacizumab (Avastin) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma
•  NCT00516607: [1811] Phase I Study of Enzastaurin and Temozolomide in Patients With Gliomas
•  NCT00515086: [1794] A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme
•  NCT00514397: [1962] Temozolomide (Temodar)and Radiation Therapy in Treating Young Patients With Pontine Glioma
•  NCT00509301: [1787] Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme
•  NCT00504660: [1780] Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma and Glioblastoma Multiforme
•  NCT00501891: [1783] A Phase II Study of Bevacizumab (Avastin) in Combination With Metronomic Temozolomide (Temodar)for Recurrent Malignant Glioma
•  NCT00499798: [1785] Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
•  NCT00499473: [1812] A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas
•  NCT00498927: [1786] A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma
•  NCT00492687: [1809] A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas
•  NCT00482677: [1816] A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients
•  NCT00473408: [1817] The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-Grade Astrocytomas
•  NCT00471653: [1826] A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide
•  NCT00463203: [1782] A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy
•  NCT00458601: [1765] Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III)
•  NCT00456612: [1825] Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status
•  NCT00452959: [1082] A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors
•  NCT00450866: [1771] Phase II Trial of Patupilone in Patients With Brain Metastases From Breast Cancer
•  NCT00445965: [1808] Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
•  NCT00441142: [1793] Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma
•  NCT00438997: [1918] A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
•  NCT00437047: [1922] A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
•  NCT00424554: [1762] A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks (Pre-Surgery) on Brain Tumor O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas.
•  NCT00418899: [1784] Gliogene: Brain Tumor Linkage Study
•  NCT00412711: [1758] Phase I/II Pazopanib Plus Lapatinib for Relapsed Malignant Glioma
•  NCT00402116: [1821] Phase 1/2 Study of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT00400920: [1761] Clinical and Molecular-Metabolic Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
•  NCT00400816: [1770] Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma
•  NCT00400322: [1888] Efficacy and Safety of Valcyte® as an Add-on Therapy in Patients With Malignant Glioblastoma and CMV Infection
•  NCT00397072: [1820] Phase II Study: Systemic Treatment With iv ZK219477-Epothilone in Recurrent Glioblastoma Patients
•  NCT00394628: [1745] A Phase 2 Multicenter Study of AQ4N in Combination With Radiotherapy and Temozolomide, for Safety, Tolerability, and Activity in Subjects With Newly Diagnosed Glioblastoma Multiforme
•  NCT00393094: [1913] A Phase II Trial of Bevacizumab (avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)
•  NCT00392327: [1779] Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
•  NCT00390299: [1744] Phase I Study of Intratumoral and/or Resection Cavity Administration of Recombinant Measles Virus Encoding Human Carcinoembryonic Antigen in Patients With Recurrent Glioblastoma Multiforme
•  NCT00381797: [1893] Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
•  NCT00379080: [1766] A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma
•  NCT00360854: [1759] Erlotinib (Tarceva) Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
•  NCT00354068: [1804] A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma
•  NCT00350727: [1769] Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma
•  NCT00337207: [1803] A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas
•  NCT00335764: [1805] Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
•  NCT00329719: [1720] Phase I/II Study of Sorafenib and Temsirolimus (CCI-779) in Patients With Recurrent Glioblastoma
•  NCT00316849: [1735] Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00314808: [1703] A Pilot Study of Dronabinol for the treatment of nausea,vomiting and appetite loss in Adult Patients With Primary Gliomas
•  NCT00313729: [1704] Phase II Study of Temozolomide in Patients With Supratentorial Low-Grade Glioma
•  NCT00313664: [1914] A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
•  NCT00311857: [1710] Treatment of Primary Glioblastoma Multiforme With Cetuximab (Erbitux), Radiotherapy and Temozolomide (GERT) – Phase I/II Trial
•  NCT00311558: [1768] Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon a-2b for Solid Tumors, Lymphoma or Myeloma
•  NCT00305864: [1723] Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
•  NCT00304044: [1920] AIDS-Related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate With Rituximab, Leucovorin Rescue and Highly Active Antiretroviral Therapy
•  NCT00304031: [1714] Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma
•  NCT00301418: [1695] Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
•  NCT00293566: [1917] A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
•  NCT00293423: [1688] Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma
•  NCT00290797: [1915] Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma
•  NCT00283569: [1718] Genetic Epidemiology of Adult-Onset Glioma
•  NCT00283543: [1716] A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion
•  NCT00280475: [1685] Randomized Phase III Trial of Postoperative Whole Brain Radiation Therapy Compared With Salvage Stereotactic Radiosurgery in Patients With One to Four Brain Metastasis: Japan Clinical Oncology Group Study (JCOG 0504)
•  NCT00276783: [1693] Phase II Study of Pemetrexed Disodium (Alimta) in Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
•  NCT00275002: [1700] Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors
•  NCT00272870: [1702] A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection
•  NCT00268385: [1679] A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas
•  NCT00253721: [1639] Melphalan and Mannitol in Treating Patients With Central Nervous System Tumors
•  NCT00253474: [936] A Phase I/II Trial of PEG-Interferon Alfa-2B (PEG-Intron) for Plexiform Neurofibromas (NF1 patients)
•  NCT00250211: [1655] Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Gliobastoma Treated With Concurrent Radiation Therapy and Temozolomide
•  NCT00247403: [1681] Phase I Clinical Trial: 2DG (2-Deoxyglucose ) + Stereotactic Radiosurgery (SRS) Protocol for Treatment of Intracranial Metastases
•  NCT00243022: [1633] Boswellia Serrata Combined With a Low-Fat, Vegan Diet or a Standard Diet Alone in Treating Patients Who Have Undergone Surgery and Radiation Therapy for Newly Diagnosed Glioblastoma Multiforme
•  NCT00238303: [1643] Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
•  NCT00238173: [1660] Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
•  NCT00213278: [1713] Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
•  NCT00209989: [1646] Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
•  NCT00209248: [851] PS-341 With Oral Temozolomide in Patients With Advanced Refractory Solid Tumors or Melanoma
•  NCT00207350: [1661] Neurosurgical Use of Interstitial Laser Therapy (ILT)
•  NCT00200161: [796] Concurrent Temozolomide and Radiotherapy Followed By Dose Dense Versus Metronomic Temozolomide and Maintenance Cis-Retinoic Acid For Patients With Newly Diagnosed Glioblastoma And Other Malignant Gliomas
•  NCT00190424: [1630] Randomized Phase 2 with CpG-ODN in Malignant Glioblastoma
•  NCT00187642: [747] A Phase II Study of Temozolomide (temodar) in the Treatment of Adult Patients with Supratentorial Low Grade Glioma
•  NCT00179907: [1648] A Phase I/II Study of Reirradiation for Recurrent Pediatric Brain and Spinal Cord Tumors and Primary Glioblastoma Multiforme Using the Photon Radiosurgery System
•  NCT00179881: [715] Thalomid™ and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
•  NCT00165477: [1637] Study of Lenalidomide and XRT in Patients with Newly Diagnosed Glioblastoma Multiforme
•  NCT00132158: [1653] ZD1839 and Oral Irinotecan in Treating Young Patients with Refractory Solid Tumors
•  NCT00128986: [1707] A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour
•  NCT00125710: [1709] Comparative 2-D Tumor Analysis in Familial Gliomas
•  NCT00124657: [1536] Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
•  NCT00114140: [1580] A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
•  NCT00112762: [1916] Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas
•  NCT00112736: [1548] NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
•  NCT00112502: [955] Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
•  NCT00109798: [1510] Phase 2 Trial of Salvage Chemotherapy with Temozolomide in Combination with Topotecan for Primary CNS Lymphoma.
•  NCT00107458: [1593] Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
•  NCT00107367: [1596] A Phase I/II Study Utilizing the Zeiss INTRABEAM System for the Treatment of a Resected Solitary Brain Metastasis
•  NCT00107185: [1842] Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients
•  NCT00100880: [1719] Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors
•  NCT00100802: [1680] Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas
•  NCT00098865: [1592] Thalidomide and Temozolomide in Treating Young Patients With Relapsed or Progressive Brain Tumors or Recurrent Neuroblastoma
•  NCT00098605: [1608] Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
•  NCT00096265: [1604] Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
•  NCT00096252: [969] Phase II Study of Brachytherapy Using the Intracavity GliaSite® Radiation Therapy System (RTS) With or Without Stereotactic Radiosurgery in Patients With Newly Diagnosed Supratentorial Brain Metastases
•  NCT00095940: [1509] A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
•  NCT00095771: [1568] Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas (Brainstem glioma, glioblastoma multiforme, gliosarcoma, anaplastic astrocytoma)
•  NCT00089245: [1601] Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
•  NCT00087230: [1354] Intratumoral Transferrin-CRM107 (Transmid) Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme
•  NCT00085254: [1168] Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00085202: [1706] Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
•  NCT00084838: [1089] Phase II Study of Multi-Agent Intrathecal and Systemic Chemotherapy With Radiotherapy in Children With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors
•  NCT00083096: [1656] Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
•  NCT00082992: [1483] Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00080938: [1603] Temozolomide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
•  NCT00079339: [1618] Tipifarnib and Radiation Therapy in Treating Young Patients with Brainstem Glioma
•  NCT00077207: [1578] Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
•  NCT00075387: [504] Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma
•  NCT00068510: [578] Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma)
•  * * * Duplicate ** NCT00068510: [1131] Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma)
•  NCT00060879: [1045] Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT00058123: [1014] Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
•  NCT00054496: [1482] Phase II Study of Erlotinib in Patients With Recurrent or Progressive Glioblastoma Multiforme
•  NCT00052650: [1494] PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
•  * * * Duplicate ** NCT00052650: [973] A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas
•  NCT00052455: [1554] Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
•  NCT00052286: [1721] Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors
•  NCT00049127: [1347] Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
•  * * * Duplicate ** NCT00049127: [1624] Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
•  NCT00049023: [1598] Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
•  NCT00047320: [618] Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
•  NCT00042991: [1507] Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
•  NCT00042367: [749] Pilot Study of Systemic and Intrathecal Chemotherapy Followed by Conformal Radiation for Infants with Brain Tumors
•  NCT00041145: [1919] A Phase II Study of Pegylated Interferon Alfa-2b (PEG-INTRON) in Children With Diffuse Pontine Gliomas
•  NCT00039494: [1544] Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
•  NCT00036569: [967] A Phase II Study of Pegylated Interferon Alfa-2b (Peg-Intron`) in Children with Diffuse Pontine Gliomas
•  NCT00031590: [804] Reduced Dose Craniospinal Radiation (1800 cGy) and Chemotherapy in children with newly-diagnosed standard-risk posterior fossa primitive neuro-ectodermal tumor (PNET/medulloblastoma )
•  NCT00031577: [787] Phase I trial to study the effectiveness of combining paclitaxel with radiation therapy in treating children who have newly diagnosed brain stem glioma.
•  NCT00027846: [1508] Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
•  NCT00004259: [1093] Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
•  NCT00004129: [1490] Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
•  NCT00003514: [1599] Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
•  NCT00003476: [1587] Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
•  NCT00003475: [1563] Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
•  NCT00003458: [1585] Antineoplaston Therapy in Treating Children With Brain Tumors
•  NCT00003457: [1562] Antineoplaston Therapy in Treating Patients With Brain Tumors
•  NCT00002899 : [1026] No Radiotherapy versus Whole Brain Radiotherapy for 1 to 3 Brain Metastases from Solid Tumor after Surgical Resection or Radiosurgery. A Randomized Phase III Trial.
•  NCT00002899: [1133] Whole Brain Radiation following surgical resection in patients with newly diagnosed brain metastases: A Phase III prospective randomized trial
•  NCT00002647: [381] Phase I study of Photodynamic Therapy with porfimer sodium for refractory brain tumors
•  NCT00001635: [1615] A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy
•  NCT00001574: [1605] A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
•  NCT0000067232: [1367] Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
•  724770: [1929] ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients with Malignant Glioma
•  00795457: [1895] A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Adults with High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Inactive Trials

Note - these mighe be duplicates, or closed trials

•  NCT00626015: [1839] Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
•  NCT00424060: [1807] Phase II Study of ZK 219477 in Patients With Recurrent Glioblastoma
•  NCT00423735: [1797] Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
•  NCT00385853: [1792] A Phase I Study of PRK787/ZK 222584 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma
•  NCT00362921: [1267] Phase II trial of Gliadel plus O6-Benzylguanine for patients with recurrent glioblastoma multiforme.
•  NCT00352521: [1814] Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Bevacizumab (Avastin) in Combination With Irinotecan (CPT-11) for Malignant Gliomas
•  NCT00305656: [1694] Phase II Study of AZD2171 in Patients With Recurrent Glioblastoma Multiforme
•  NCT00275067: [1684] Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
•  NCT00268359: [1689] Phase II Study of Bevacizumab (Avastin) and Irinotecan Hydrochloride (CPT-11) in Patients With Recurrent or Refractory Grade 3 or 4 Malignant Gliomas
•  NCT00267592: [1672] Phase II Trial of Talampanel in Conjunction With Radiation Therapy With Recurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00253448: [1644] Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
•  NCT00227032: [1635] Safety and Pharmacokinetics Study of Erlotinib (Tarceva) to Treat Patients with Recurrent Glioblastoma Multiforme.
•  * * * Duplicate ** NCT00227032: [1256] Phase II, multicenter, open-label trial of the safety and efficacy of Tarceva in patients with first relapse of grade IV glioma (glioblastoma multiforme)
•  NCT00179803: [1649] Phase II Prospective Study of Sequential Myeloablative Chemotherapy with Stem Cell Rescue for the Treatment of Selected High Risk CNS Tumors and Recurrent CNS Tumors.
•  NCT00171938: [1645] Open-Label Trial of Imatinib Mesylate (Gleevec) in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
•  NCT00147056: [1654] A Feasibility Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Lesions
•  NCT00128700: [1641] Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00119288: [1632] Cilengitide in Treating Patients With Recurrent Glioblastoma Multiforme
•  NCT00118222: [382] Photodynamic Therapy Using Porfimer Sodium in Treating Patients Who Are Undergoing Surgery for Recurrent Malignant Astrocytoma
•  NCT00114309: [1739] A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma
•  NCT00112619: [1594] Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
•  NCT00107237: [1540] AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
•  NCT00105014: [1567] Interleukin-13 PE38QQR Immunotoxin and Radiation Therapy With or Without Temozolomide in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Malignant Glioma
•  NCT00103038: [1573] Magnetic Resonance Imaging Using Ferumoxytol in Patients With Primary Brain Cancer or Brain Metastases From Lung or Breast Cancer
•  NCT00102648: [1486] Phase I Study of Sarasar and Temodar in Patients with Recurrent or Temodar-Refractory Glioblastoma Multiforme
•  * * * Duplicate ** NCT00102648: [726] A phase II study of temozolomide (continuous low dose) for the treatment of recurrent malignant glioma
•  NCT00099125: [1546] Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00095940: [1590] Lapatinib in Treating Young Patients With Recurrent or Refractory CNS Tumors
•  NCT00093964: [1477] Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
•  NCT00093613: [1559] Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
•  NCT00090597: [1122] A Complementary Trial of an Immunotherapy Vaccine Against Tumor-Specific EGFRvIII
•  * * * Duplicate ** NCT00090597: [1259] A Complementary Trial of an Immunotherapy Vaccine Against Tumor-Specific EGFRvIII
•  NCT00089245: [868] Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
•  NCT00085735: [28] Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
•  NCT00085566: [1485] Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
•  NCT00079339: [1233] PBTC014: Phase I/II Trial of R115777 and XRT in Pediatric Patients with Newly Diagnosed Non-Disseminated Intrinsic Diffuse Brainstem Gliomas
•  NCT00075387: [1495] Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma
•  NCT00068666: [1616] Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
•  NCT00054496: [982] Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
•  NCT00052208: [1094] Phase I/II Study of an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), ZD 1839 (Iressa) with Radiation Therapy in GBM
•  * * * Duplicate ** NCT00052208: [1112] Phase I/II Iressa + RT for treatment of previously untreated GBM.
•  NCT00049387: [1545] Tipifarnib, Temzolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  * * * Duplicate ** NCT00049387: [995] Tipifarnib, Temzolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT00049127: [806] Phase I/II Trial of STI-571 (Gleevec) in Patients With Recurrent Malignant Gliomas
•  * * * Duplicate ** NCT00049127: [810] Phase I/II Study of Imatinib Mesylate (Gleevec ) in Patients With Recurrent Oligodendroglioma or Mixed Oligoastrocytoma
•  NCT00047320: [614] Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
•  NCT00047281: [1281] Pilot study of Oral Thalidomide plus Cyclophosphamide for children with recurrent or progressive brain tumors.
•  NCT00045968: [1750] Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer
•  NCT00042991: [977] Phase II Study of Gefitinib and Brain Irradiation in Children With Newly Diagnosed Brain Stem Tumors or Incompletely Resected Supratentorial Malignant Gliomas
•  * * * Duplicate ** NCT00042991: [991] Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
•  NCT00042367: [19] Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors
•  NCT00039572: [874] A Phase I/II Trial of Neutron Capture Therapy (NCT) for Glioblastoma Multiforme and Intracranial Melanoma
•  * * * Duplicate ** NCT00039572: [1479] Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain
•  NCT00039468t: [1351] Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy
•  NCT00039468: [1352] Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy
•  NCT00039364: [1025] Open Label Phase II Study on STI571 Administered As a daily Oral Treatment In Gliomas
•  NCT00031083: [931] Phase 1 trial of IFN-Beta Gene Transfer in the Treatment of Glioblastoma Multiforme
•  * * * Duplicate ** NCT00031083: [334] Phase 2 Trial Of Recombinant Human Interferon Beta In The Treatment Of Patients With Recurrent Glioma
•  NCT00030628: [981] A Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to three Cerebral Metastases
•  * * * Duplicate ** NCT00030628: [959] A Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in patients with One to Three Cerebral Metastasis
•  * * * Duplicate ** NCT00030628: [1019] A Phase II Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to radiosurgery in the Management of Patients with One to Three Cerebral Metastases
•  * * * Duplicate ** NCT00030628: [186] Phase 2 Study of Radiosurgery as an Adjunct to External Radiation for the Treatment of Patients With Newly Diagnosed Metastatic Brain Tumor
•  * * * Duplicate ** NCT00030628: [1309] Z0300: Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to Three Cerebral Mets
•  NCT00027846: [1087] Phase II Study of Conformal Radiotherapy For Pediatric Patients With Localized Ependymoma, Chemotherapy Prior to Second Surgery in Pediatric Patients With Incompletely Resected Ependymoma, and Observation Only in Pediatric Patients With Completely Resected Differentiated, Supratentorial Ependymoma
•  NCT00025558: [30] Intensive Chemotherapy with Autologous Bone Marrow Transplant or Stem Cell Rescue (Plus Focal Radiotherapy for Ages >3 Years Old) for Pediatric Anaplastic Astrocytoma, Glioblastoma Multiforme and High Risk PNETs.
•  NCT00017147: [1113] Phase III O6 BG/BCNU + RT vs. BCNU + RT for treatment of GBM
•  NCT00014443: [1552] Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
•  NCT00008008 (Duplicate): [1565] Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Malignant Glioma
•  NCT00006386: [905] RTOG 0023 A Phase II Trial of Accelerated Radiotherapy Using Weekly Stereotactic Conformal Boosts for Supratentorial Glioblastoma Multiforme.
•  NCT00006355: [847] A Phase I/II Study of Pyrazoloacridine (PZA) in Adults with Newly Diagnosed Malignant Glioma
•  * * * Duplicate ** NCT00006355: [742] NABTT Trial: Phase I/II Study of Pyraxolacridin (PZA) in Adults with Newly Diagnosed Glioblastoma Multiforme
•  * * * Duplicate ** NCT00006355: [813] Phase I/II Study of Pyrazoloacridine (PZA) in Adults with Newly Diagnosed Glioblastoma Multiforme.
•  * * * Duplicate ** NCT00006355: [1032] Phase I/II Study of Pyrazoloacridine (PZA) in Adults with Newly diagnosed Glioblastoma Multiforme
•  NCT00006263: [935] Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
•  NCT00006238: [550] Phase I/II Evaluation of Phenylbutyrate in Adults with Recurrent Malignant Gliomas
•  NCT00006024: [938] A Phase I Study of Temozolomide and CCNU in Pediatric Patients with newly diagnosed Incompletely Resected Non-Brainstem High Grade Gliomas
•  NCT00005602: [937] Phase I Study of Concurrent Cereport and Carboplatin with Radiation Therapy for Children with Newly Diagnosed Brain Stem Gliomas
•  NCT00004259: [906] RTOG 9813 A Phase I/III Randomized Study of Radiation Therapy and Temozolomide versus Radiation Therapy and BCNU versus Radiation Therapy and Temozolomide and BCNU for Anaplastic Astrocytoma.
•  * * * Duplicate ** NCT00004259: [864] SWOG (RTOG) 98-13 randomized trial of RT + Temozolomide vs RT + BCNU, versus RT+ Tem + BCNU
•  * * * Duplicate ** NCT00004259: [1062] Phase I/II Randomized Study of Radiation Therapy and Temozolomide Versus Radiation Therapy and BCNU Versus Radiation Therapy and Temozolomide and BCNU for Anaplastic Astrocytoma
•  NCT00004129: [585] Phase I Study of Interstitial Colloidal Phosphorus P32 in Patients With Recurrent or Poor Prognosis Grade 4 Astrocytoma
•  NCT00004073: [595] Phase II Study of Suramin and Concurrent Radiation Therapy in Newly Diagnosed GBM
•  NCT00004024: [132] Phase 1/2 Study of Monoclonal Antibody (OKT-3) And Cyclophosphamide in Patients With Advanced Brain Tumors.
•  NCT00004015: [1627] Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
•  NCT00003916: [884] A Phase II Trial of Accelerated Radiotherapy using weekly sterotactic conformal boosts for supratentorial glioblastoma multiforme
•  NCT00003846: [604] Treatment of High Risk Central Nervous System Embryonal Tumors with Conventional Radiotherapy and Intensive Consolidation Chemotherapy with Peripheral Blood Progenitor Cell (PBSC) Support
•  NCT00003775: [503] Phase 2 open label study of SU101 for patients with anaplastic astrocytoma in first relapse
•  NCT00003751: [1068] Phase II Trial of Surgical Resection, Gliadel Wafer, and Irradiation Followed by Penicillamine/Low Copper Diet for Newly Diagnosed Glioblastoma Multiforme
•  NCT00003567 (Duplicate): [1564] Gene Therapy Plus Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin`s Lymphoma
•  NCT00003478: [1254] Phase I/II study of Anti-Tenascin Monoclonal Antibody 131I-Labeled 81C6 via surgically created cystic resection cavity in the treatment of patients with malignant CNS tumors.
•  NCT00003462: [1009] Intrathecal busulfan chemotherapy for patients with neoplastic meningitis (carcinomatous or lymphomatous meningitis).
•  NCT00003375: [945] RTOG 9802: A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase III Study of Radiation with or without PCV Chemotherapy in Unfavorable Low-Grade Glioma
•  * * * Duplicate ** NCT00003375: [560] Observation in Favorable Low-Grade Glioma and Phase III Study of RT +/- PCV Chemo in Unfavorable Low-Grade Glioma
•  NCT00003324: [1230] A Phase II Study Utilizing Focal Radiation in patients With 1-3 Brain Metastases.
•  NCT00003185: [121] Phase 1 Study of Adoptive Cellular Immunotherapy Plus IL-2 in Patients With Recurrent High Grade Gliomas or Metastases to the Brain.
•  NCT00003073: [958] A Randomizwed clinical study to determine the Patient Benefit and Safety of DEPOCYT(Cytarabine Liposome Injection) for the Treatment of Neoplastic Meningitis
•  NCT00002986: [1252] Phase II treatment with Topotecan plus BCNU for patients with primary malignant glioma.
•  NCT00002882: [533] Phase 2 pilot trial of concurrent biochemotherapy with Cisplatin, Vinblastine, Temozolomide, IL-2, and Interferon Alpha 2B in patients with metastatic malignant melanoma
•  * * * Duplicate ** NCT00002882: [539] Phase 2 study of modified biochemotherapy for advanced Melanoma.
•  * * * Duplicate ** NCT00002882: [538] Phase 2 study of outpatient concurrent chemo-biotherapy (Cisplatin, Temozolomide (Temodal), IL-2 and Interferon Alpha 2b) for the treatment of metastatic malignant melanoma
•  NCT00002814: [386] Phase II study of Paclitaxel/Topotecan/G-CSF for recurrent glioblastoma multiforme or anaplastic astrocytoma
•  NCT00002619: [115] High dose chemotherapy with autologous stem cell rescue for patients aged less than 60 years with recurrent malignant brain tumors in "minimal" residual disease.
•  NCT00001807: [727] Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in patients who receive Neurotoxicic Therapy
•  NCT00001574: [599] Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic (NMRS) Imaging in Pediatric Patients with Primary Brain Tumors
•  06BG, BCNU: [966] SWOG S0001 Randomized trial of radiation + BCNU, +/- O6BG
•  00777153: [1907] Phase III Randomized, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Subjects to Compare the Efficacy of AZD2171 [RECENTIN] Monotherapy and the Combination of AZD2171 with Lomustine to the Efficacy of Lomustine Alone
•  00114140: [1908] RTOG 0424 A Phase II Study of Temozolomide-Based Chemoradiotherapy Regimen for High Risk Low-Grade Gliomas